| Literature DB >> 9035298 |
S Hayashi1, N Emi, I Yokoyama, K Uchida, H Takagi.
Abstract
Hepatic metastasis of colon cancer is an important prognostic factor for survival. In this study, we examined the effect of gene therapy using the herpes simplex virus-thymidine kinase (HS-tk) gene with short-course ganciclovir (GCV) treatment for multiple hepatic metastases of murine colon cancer. Colon26 cells transfected with the HS-tk gene were found to be sensitive to GCV in a concentration-dependent way. On the other hand, induction of the HS-tk gene in the cells had no influence on cell growth in vitro. However, multiple hepatic metastases of Colon26 cells transfected with HS-tk gene were significantly suppressed by the GCV treatment. These results thus suggest that HS-tk gene therapy is useful for the treatment of hepatic metastasis in colon cancer.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9035298 DOI: 10.1007/bf01366937
Source DB: PubMed Journal: Surg Today ISSN: 0941-1291 Impact factor: 2.549